Literature DB >> 17554536

Berardinelli-Seip lipodystrophy.

Yuko Kobashi1, Amy Schoenbaum, Robert P Hasserjian, Daniel I Rosenthal.   

Abstract

Berardinelli-Seip lipodystrophy (BSCL) is a rare, but widely distributed, congenital disorder of metabolism. It is characterized by insulin-resistant diabetes mellitus and marked deficiency of adipose tissue. The clinical and imaging features of the syndrome are mostly due to fat deficiency, diabetes, or to manifestations of secondary hyperinsulinemia, which results from the failure of the tissues to respond to insulin. Absence of fat may be generalized, or depending upon the subtype of the disease, may not affect areas where fat plays a mechanical function, such as the palms and soles. Muscles appear hypertrophic. In addition, characteristic, but idiopathic, peri-articular lytic lesions may be seen in some individuals. The combination of imaging, clinical, and laboratory findings is characteristic and readily recognized once the components of the syndrome are known.

Entities:  

Mesh:

Year:  2007        PMID: 17554536     DOI: 10.1007/s00256-007-0332-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  14 in total

1.  Lipodystrophic muscular hypertrophy.

Authors:  B SENIOR
Journal:  Arch Dis Child       Date:  1961-08       Impact factor: 3.791

2.  An undiagnosed endocrinometabolic syndrome: report of 2 cases.

Authors:  W BERARDINELLI
Journal:  J Clin Endocrinol Metab       Date:  1954-02       Impact factor: 5.958

3.  Diabetes, obesity, and the brain.

Authors:  Michael W Schwartz; Daniel Porte
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

4.  Marrow changes in anorexia nervosa masking the presence of stress fractures on MR imaging.

Authors:  Bernhard Tins; Victor Cassar-Pullicino
Journal:  Skeletal Radiol       Date:  2005-11-25       Impact factor: 2.199

5.  Gelatinous transformation of the bone marrow.

Authors:  J P Seaman; C R Kjeldsberg; A Linker
Journal:  Hum Pathol       Date:  1978-11       Impact factor: 3.466

6.  Leptin-replacement therapy for lipodystrophy.

Authors:  Elif Arioglu Oral; Vinaya Simha; Elaine Ruiz; Alexa Andewelt; Ahalya Premkumar; Peter Snell; Anthony J Wagner; Alex M DePaoli; Marc L Reitman; Simeon I Taylor; Phillip Gorden; Abhimanyu Garg
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

7.  A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.

Authors:  A Garg; R Wilson; R Barnes; E Arioglu; Z Zaidi; F Gurakan; N Kocak; S O'Rahilly; S I Taylor; S B Patel; A M Bowcock
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

8.  Premature atherosclerosis associated with monogenic insulin resistance.

Authors:  R A Hegele
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

9.  Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.

Authors:  L Van Maldergem; J Magré; T E Khallouf; T Gedde-Dahl; M Delépine; O Trygstad; E Seemanova; T Stephenson; C S Albott; F Bonnici; V R Panz; J L Medina; P Bogalho; F Huet; S Savasta; A Verloes; J J Robert; H Loret; M De Kerdanet; N Tubiana-Rufi; A Mégarbané; J Maassen; M Polak; D Lacombe; C R Kahn; E L Silveira; F H D'Abronzo; F Grigorescu; M Lathrop; J Capeau; S O'Rahilly
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

Review 10.  Measuring muscle lipids with 1H-MR spectroscopy.

Authors:  Martin Torriani
Journal:  Skeletal Radiol       Date:  2007-07       Impact factor: 2.128

View more
  1 in total

1.  Exercise Increases Bone in SEIPIN Deficient Lipodystrophy, Despite Low Marrow Adiposity.

Authors:  Cody McGrath; Sarah E Little-Letsinger; Jeyantt Srinivas Sankaran; Buer Sen; Zhihui Xie; Martin A Styner; Xiaopeng Zong; Weiqin Chen; Janet Rubin; Eric L Klett; Rosalind A Coleman; Maya Styner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-25       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.